
Read More
Stocks to Watch Tomorrow...
Drug approval, a strategic acquisition and a Rs 359 crore railway contract have put Emcure, Krishca ...

Drug approval, a strategic acquisition and a Rs 359 crore railway contract have put Emcure, Krishca ...

The stock is up by 26 per cent from its 52-week low of Rs 196.05 per share....

Shares of the company have gained more than 120 per cent in the last one year....